Dare Bioscience
DARE
18 hedge funds and large institutions have $52M invested in Dare Bioscience in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
+$21.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.6M |
| 3 |
PVMCI
Polaris Venture Management Co IV
Boston,
Massachusetts
|
+$9.25M |
| 4 |
WSA
Wall Street Associates
Lajolla,
California
|
+$3.05M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$2.89M |
Top Sellers
DARE Hedge Fund Activity: Q2 2014 in Review
18 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q2 2014, worth a combined $52M.
Buyers outnumbered sellers: 18 funds opened new DARE positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Polaris Venture Management Co V, opening a new position worth an estimated $21.1M.
- 18 institutional investors held Dare Bioscience (DARE) as of Q2 2014, up from 0 in Q1 2014.
- Funds reported $52M of Dare Bioscience stock for Q2 2014.
- 18 funds opened new Dare Bioscience positions in Q2 2014 and 0 closed out, a net change of +18 holders.
- The largest Dare Bioscience buyer in Q2 2014 was Polaris Venture Management Co V, an estimated $21.1M added.
Based on aggregated 13F filings for Q2 2014.